IP Library › Granted Patent US 11,427,866
Granted Patent B2
US 11,427,866 · App. 16/301,707 · Granted Aug 30, 2022

Method of improved sequencing by strand identification

Inventors: Malek Faham (Burlingame, CA); Shengrong Lin (Fremont, CA); Ling Fung Tang (San Francisco, CA); Yontao Lu (Sunnyvale, CA); Zhaohui Sun (Albany, CA); Yingyu Wang (Mountain View, CA); Li Weng (Fremont, CA)
Assignee: ACCURAGEN HOLDINGS LIMITED
C12Q1/6869C12Q1/6827C12Q1/6858C40B50/06C12Q2521/501C12Q2535/139C12Q2537/143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,427,866
App. No.
16/301,707
Granted
Aug 30, 2022
Kind
B2
Abstract

In some aspects, the present disclosure provides methods for identifying sequence variants, as well as methods of determining copy number of a genetic locus in a sample. Systems and kits for performing methods of the disclosure, as well as compositions produced by or useful in methods of the disclosure are also provided. In some embodiments, methods comprise extending 3′ ends of polynucleotides by adding one or more pre-determined nucleotides. In some embodiments, methods comprise use of a strand-tagging sequence.

Claims (28)

1. A method of identifying complementary strands in a nucleic acid sample comprising a plurality of double-stranded polynucleotides, each double-stranded polynucleotide of the plurality comprising a first complementary strand and a second complementary strand, each having a 5′ end and a 3′ end, the method comprising:

(a) modifying a polynucleotide sequence of at least one of a first complementary strand and a second complementary strand of individual double-stranded polynucleotides by adding one or more predetermined nucleotides in a base by base manner to the 3′ end of at least one of the first complementary strand and the second complementary strand;

(b) circularizing a plurality of first complementary strands and a plurality of second complementary strands to form a plurality of single stranded polynucleotide circles, the one or more predetermined nucleotides defining a boundary between 3′ sequences and 5′ sequences of each single stranded polynucleotide circle;

(c) amplifying by rolling circle amplification the single stranded polynucleotide circles to form a plurality of concatemers;

(d) sequencing said plurality of concatemers, to yield a plurality of sequencing reads; and

(e) identifying from the plurality of sequencing reads, a given first complementary strand and a given second complementary strand as originating from a common double-stranded polynucleotide based on (i) sequences of the respective 3′ ends and 5′ ends adjacent to the one or more predetermined nucleotides, and (ii) sequences of the one or more predetermined nucleotides.

2. The method of claim 1 , wherein modifying a polynucleotide sequence further comprises attaching a polynucleotide having a predefined polynucleotide sequence to a 5′ end, a 3′ end, or both 5′ and 3′ ends of at least one of the first complementary strand and the second complementary strand or altering at least one nucleotide of the polynucleotide sequence.

3. The method of claim 2 , wherein modifying the polynucleotide sequence comprises altering at least one nucleotide of the polynucleotide sequence, and altering at least one nucleotide of the polynucleotide sequence is effected by treatment with bisulfite.

4. The method of claim 1 , further comprising identifying two first complementary strands or two second complementary strands as originating from different double-stranded polynucleotides based on extension of the respective 3′ ends by a different number of predetermined nucleotides.

5. The method of claim 4 , wherein the step of amplifying the extended polynucleotides comprises extending a primer hybridized to an adaptor polynucleotide.

6. The method of claim 1 , wherein circularizing is effected by subjecting the extended polynucleotides to a ligation reaction.

7. The method of claim 1 , wherein the polynucleotides are denatured to form single-stranded polynucleotides prior to circularization.

8. The method of claim 1 , wherein amplification produces linear concatemers, and further wherein each concatemer comprises more than one copy of the corresponding circularized polynucleotide, or a complement thereof.

9. The method of claim 1 , wherein the amplifying comprises extension of random primers.

10. The method of claim 1 , wherein the primers comprise a tag sequence, a sequencing primer binding sequence, or both.

11. The method of claim 1 , wherein the amplifying comprises extension of one or more primers specific to a target sequence.

12. A method of identifying a sequence variant in a nucleic acid sample comprising a plurality of double-stranded polynucleotides, each double-stranded polynucleotide of the plurality comprising a first complementary strand and a second complementary strand, each having a 5′ end and a 3′ end, the method comprising:

(a) modifying a polynucleotide sequence of at least one of a first complementary strand and a second complementary strand of individual double-stranded polynucleotides by adding one or more predetermined nucleotides in a base by base manner to the 3′ end of at least one of the first complementary strand and the second complementary strand;

(b) circularizing a plurality of first complementary strands and a plurality of second complementary strands to form a plurality of single stranded polynucleotide circles, the one or more predetermined nucleotides defining a boundary between 3′ sequences and 5′ sequences of each single stranded polynucleotide circle;

(c) amplifying by rolling circle amplification the single stranded polynucleotide circles to form a plurality of concatemers;

(d) sequencing a plurality of first complementary strands and a plurality of second complementary strands, or amplification products thereof, to yield a plurality of sequencing reads;

(e) identifying from the plurality of sequencing reads, a given first complementary strand and a given second complementary strand as originating from a common double-stranded polynucleotide based on (i) sequences of the respective 3′ end and 5′ ends adjacent to the one or more predetermined nucleotides, and (ii) sequences of the one or more predetermined nucleotides;

(f) comparing polynucleotide sequences of the given first complementary strand and the given second complementary strand originating from the common double-stranded polynucleotide; and

(g) calling a sequence difference in the given first complementary strand relative to a reference sequence as the sequence variant only when the given second complementary strand originating from the common double-stranded polynucleotide comprises a complement of the sequence difference.

13. The method of claim 12 , wherein modifying a polynucleotide sequence further comprises attaching a polynucleotide having a predefined polynucleotide sequence to a 5′ end, a 3′ end, or both 5′ and 3′ ends of at least one of the first complementary strand and the second complementary strand or altering at least one nucleotide of the polynucleotide sequence.

14. The method of claim 13 , wherein modifying the polynucleotide sequence comprises altering at least one nucleotide of the polynucleotide sequence, and altering at least one nucleotide of the polynucleotide sequence is effected by treatment with bisulfite.

15. The method of claim 12 , further comprising joining an adaptor polynucleotide to the 3′ end of: (i) one or both strands of the double-stranded polynucleotides; or (ii) the extended polynucleotides.

16. The method of claim 12 , wherein amplification produces linear concatemers, and further wherein each concatemer comprises more than one copy of the corresponding circularized polynucleotide, or a complement thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2025
From: ACCURAGEN HOLDINGS LIMITED
To: ACCUSCAN SCIENCES INC.
Reel/Frame 074035/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2019
From: FAHAM, MALEK; LIN, SHENGRONG; TANG, LING FUNG; LU, YONTAO; SUN, ZHAOHUI; WANG, YINGYU; WENG, LI
To: ACCURAGEN HOLDINGS LIMITED
Reel/Frame 047919/0683 →
Continuity (3)
Provisional Application 62337296 · May 16, 2016
Provisional Application 62506390 · May 15, 2017
Related Publication 20200010884A1 · Jan 9, 2020
Cited By (2)
US 12,234,512 US 12,247,252